Dr. Marijn Dekkers, Bayer chief executive, 2010-2016 However, before we get into the history of this German pharmaceutical company, it’s a good idea to get your head around the different names ...
An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...
Bayer AG reported positive results for elinzanetant ... treatment expected to launch as early as this year. The German company’s drug met all the goals of a late-stage study for the treatment ...
The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...
The agreement with Bayer Leverkusen is complete, writes Gianluca Di Marzio of Sky Sport. The German side will welcome Hermoso on a dry loan with salary entirely covered by them. According to Di ...
The company is the Indian subsidiary of Bayer Germany which is a diversified international chemical and healthcare company. They diversified into inorganic-chemistry-related fields like hard ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...
LEVERKUSEN, Germany--(BUSINESS WIRE)--The Federal ... reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback